Governance in the biotechnology industry tends to be discussed in the language of constraint. Compliance obligations. Fiduciary duties. Risk management frameworks. The board as a check on management rather than a force that shapes what management is able to attempt. Leen Kawas has spent her career working in and around governance structures that she regards […]

Biotechnology is an industry built on possibility. Each discovery carries the potential to alter the course of disease, extend lives, or transform care. Yet the path from discovery to impact is rarely straightforward. For Leen Kawas, scientist, entrepreneur, and venture investor, the central question has always been: how do we ensure that science reaches the […]